What Happened
An ICU registered nurse at HCA Midwest Research Medical Center in Kansas City, Missouri, obtained fentanyl by fraud and tampered with a compounded IV bag intended for a patient.
On April 4, 2019, she ordered a compounded fentanyl IV bag from the hospital pharmacy using another name, falsely claiming a patient's fentanyl bag had run dry and a replacement was needed. She signed a false name on the pharmacy delivery signature receipt. A pharmacist recognized the patient's name — he had delivered a fentanyl bag for that same patient an hour earlier — and checked on the patient, finding the original bag still at the bedside. The pharmacist confronted her; she claimed it was a mistake, and the bag was returned to the pharmacy.
The tamper seal over the IV port of the returned bag was torn and the patient sticker was wrinkled, as if the bag had been squeezed. She admitted extracting fentanyl from the bag and replacing it with an unknown liquid to conceal the theft. She pleaded guilty on June 18, 2020, to obtaining a controlled substance by fraud, a charge carrying up to four years in federal prison, with sentencing pending at the time of the announcement.
What Went Wrong
This case illustrates how quickly diversion can be caught when front-line staff notice anomalies — and how much harder it is to catch when orders, receipts, and administration documentation are not independently reconciled. Key failures included:
- The pharmacy filled a compounded fentanyl order without verifying the request against a current prescriber order for the named patient, leaving room for a fraudulent duplicate request.
- Delivery signature receipts were not reconciled against the requester's identity or the patient's chart, so a false signature went unnoticed at the time of pickup.
- No closed-loop check tied each dispensed bag to documented administration, so a bag ordered in a patient's name but never administered would not have been flagged on its own.
- Reliance on informal recognition — the pharmacist happened to remember the patient — rather than systematic verification meant detection depended on chance.
How It Could Have Been Prevented
- Require pharmacy to verify every compounded controlled substance request against the prescriber's active order and the patient census before dispensing.
- Reconcile delivery signatures against the ordering clinician and patient record, flagging mismatches or duplicate deliveries for immediate review.
- Track every dispensed controlled substance bag to documented administration or witnessed waste, escalating any bag that disappears without either.
- Inspect returned or unused controlled substance bags for seal and label integrity before restocking, and quarantine any bag with signs of tampering.
- Benchmark individual ordering and pickup patterns against unit peers, alerting on out-of-pattern requests for high-risk products.
Related Guidance
- Tough Issues — High-risk scenarios with annotated SQL for analyzing order-fraud patterns and dispense-to-administer gaps.
- Pharmacist's Corresponding Responsibility — The pharmacist's legal duty to ensure controlled substance orders are legitimate before dispensing.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators including duplicate ordering and documentation irregularities.
- Hospital Diversion Prevention Checklist — Hospital self-assessment, 8 sections 63 items, including compounding and dispensing controls.
- Employee Screening & Fitness for Duty — DEA screening requirements (21 C.F.R. §1301.90) and pre-employment vetting for staff with controlled substance access.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients and offer bloodborne pathogen testing.
- Camera Setup — Placement, retention, and daily obstruction checks for high-risk medication areas.